乳腺癌
医学
临床试验
癌症
癌症治疗
精密医学
靶向治疗
药物输送
模块化设计
医学物理学
转化研究
转移性乳腺癌
癌症治疗
个性化医疗
靶向给药
临床实习
药品
重症监护医学
药物发现
肿瘤科
癌症影像学
药物开发
精确肿瘤学
临床疗效
生物信息学
全身疗法
纳米医学
纳米技术
内科学
作者
Yu Sun,Rongxin Guo,Tao Xu,Chenrui Jiang,Feifei Chen,Hongbin Xu,Yaping He
标识
DOI:10.1080/17425247.2026.2747552
摘要
INTRODUCTION: Effective diagnostic and therapeutic strategies for cancer remain limited by poor specificity, systemic toxicity, and biological barriers because of the heterogeneity of cancers. To overcome these obstacles, nanomedicines have been increasingly explored. Among the different nanoscale systems, metal-organic frameworks (MOFs) are promising platforms because of their ultra-high porosity, modular chemical composition, and tunable architecture by design. Moreover, MOFs can facilitate both drug release for cancer treatment and imaging through the combination of imaging agents and therapeutics. AREAS COVERED: A comprehensive review of the properties, benefits, and clinical trials of MOFs for breast cancer diagnosis and treatment is lacking. We review the current status and advances of MOFs used for breast cancer diagnosis and drug delivery using publications primarily from PubMed through July 2026. We also discuss new strategies that take advantage of the unique physicochemical properties of MOFs for breast cancer theranostics. EXPERT OPINION: Multifunctional nanoplatforms based on MOFs have promise in revolutionizing precision oncology in breast cancer. With the ongoing developments in synthetic chemistry, bioengineering, and computer modeling, MOFs may represent resources for personalized therapeutics combining diagnosis, treatment, and monitoring of response. Subsequent interdisciplinary investigations will be important in translating the preclinical findings into clinical applications.
科研通智能强力驱动
Strongly Powered by AbleSci AI